Structural alterations in the heart after long-term L-NAME and D-NAME treatment

Gen Physiol Biophys. 1999 Dec:18 Suppl 1:6-9.

Abstract

N(G)-nitro-D-arginine methyl ester (D-NAME), considered as an inactive enantiomer of NAME, is generally used as a negative control for NO synthase inhibition with L-NAME. The aim of this work was to compare the effect of L-NAME (20 and 40 mg/kg/day), and D-NAME (40 mg/kg/day) on hemodynamic and structural parameters in the rat cardiovascular system. After 4 weeks of treatment, blood pressure and left ventricle weight/body weight ratio increased significantly in all studied groups versus control. Myocardial fibrosis (in %) represented 0.94 +/- 0.04 in control, 4.70 +/- 0.39 in L-NAME (20 mg/kg/day), 10.54 +/- 0.91 in L-NAME (40 mg/kg/day) and 5.25 +/- 0.46 in D-NAME (40 mg/kg/day) group. We conclude that in a long-term experiment D-NAME provokes similar changes in cardiovascular system like L-NAME.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Enzyme Inhibitors / toxicity
  • Fibrosis
  • Heart / drug effects*
  • Heart / physiopathology
  • Hypertrophy, Left Ventricular / chemically induced
  • Hypertrophy, Left Ventricular / pathology
  • Male
  • Myocardium / pathology
  • NG-Nitroarginine Methyl Ester / chemistry
  • NG-Nitroarginine Methyl Ester / toxicity*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Rats
  • Rats, Wistar
  • Stereoisomerism

Substances

  • Enzyme Inhibitors
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester